Serveur d'exploration sur la visibilité du Havre

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

THU0440 Yersinia Enterocolitica Biotype 1A Infection can Trigger Reactive Arthritis

Identifieur interne : 000735 ( Istex/Curation ); précédent : 000734; suivant : 000736

THU0440 Yersinia Enterocolitica Biotype 1A Infection can Trigger Reactive Arthritis

Auteurs : R. Tuompo ; T. Hannu [Finlande] ; A. Siitonen [Finlande] ; M. Leirisalo-Repo

Source :

RBID : ISTEX:BCA9777D929C1E70584B38C4D9896252B982D14B

Abstract

Background Yersinia enterocolitica (YE) is a well-known trigger of reactive arthritis (ReA) [1]. Studies of YE-related ReA have concentrated on the traditionally pathogenic serotypes O:3 and O:9 (biotypes 4 and 2, respectively) [2, 3]. Biotype 1A is generally considered non-pathogenic [4]. However, biotype 1A has been isolated from stools of diarrheic patients, and the potential pathogenicity of biotype 1A has been discussed in the literature [5, 6]. Objectives To study the capability of YE biotype 1A to induce ReA and other reactive musculoskeletal (MS) symptoms. Methods 406 questionnaires were sent to cases with positive stool culture of YE. Analysis of self-reported MS symptoms was supplemented with a clinical examination of subjects with recent MS symptoms. Results Of the 295 subjects, who returned the questionnaire, 120 reported MS symptoms, of which 114 were included to the final analysis. Among these 114 patients, 77 (68%) had YE biotype 1A, 16 (14%) had YE biotype 4, and one (0.9%) had biotype 2 infection; the remaining 20 (17%) patients had different YE-like strains or had a non-biotypable strain in the stool specimens. Of the subjects, 18% (21/114) fulfilled the criteria for ReA, and a further 12% (14/114) had other reactive MS symptoms (tendinitis or enthesitis). The incidence of ReA was 6% in cases with YE biotype 1 A and 5.4% in cases with biotypes 4 or 2. Conclusions YE biotype 1A can be a causative agent for ReA. Therefore, it should be included among pathogens searched at the diagnostic work up of the aetiology of ReA. References Leirisalo-Repo M. Reactive arthritis. Scand J Rheumatol 2005;34:251-9. Leirisalo M, Skylv G, Kousa M, et al. Followup study on patients with Reiter’s disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982;25:249-9. Schiellerup P, Krogfelt KA, Locht H. A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27.J Rheumatol. 2008;35:480-7. Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997;10:257-76. Tennant SM, Grant TH, Robins-Browne RM. Pathogenicity of Yersinia enterocolitica biotype 1A. FEMS Immunol Med Microbiol 2003;38:127-37. Bhagat N, Virdi JS. The enigma of Yersinia enterocolitica biovar 1A. Crit Rev Microbiol 2010;37:1-15. Disclosure of Interest None Declared

Url:
DOI: 10.1136/annrheumdis-2013-eular.968

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:BCA9777D929C1E70584B38C4D9896252B982D14B

Curation

No country items

R. Tuompo
<affiliation>
<mods:affiliation>Department of Medicine, Division of Rheumat, Helsinki University Central Hospital</mods:affiliation>
<wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>
M. Leirisalo-Repo
<affiliation>
<mods:affiliation>Department of Medicine, Division of Rheumat, Helsinki University Central Hospital</mods:affiliation>
<wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">THU0440 Yersinia Enterocolitica Biotype 1A Infection can Trigger Reactive Arthritis</title>
<author>
<name sortKey="Tuompo, R" sort="Tuompo, R" uniqKey="Tuompo R" first="R." last="Tuompo">R. Tuompo</name>
<affiliation>
<mods:affiliation>Department of Medicine, Division of Rheumat, Helsinki University Central Hospital</mods:affiliation>
<wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Hannu, T" sort="Hannu, T" uniqKey="Hannu T" first="T." last="Hannu">T. Hannu</name>
<affiliation wicri:level="4">
<mods:affiliation>Hjelt Institute, Department of Public Health, University of Helsinki</mods:affiliation>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Siitonen, A" sort="Siitonen, A" uniqKey="Siitonen A" first="A." last="Siitonen">A. Siitonen</name>
<affiliation wicri:level="1">
<mods:affiliation>Bacteriology Unit, National Institute of Health and Welfare, Helsinki, Finland</mods:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Bacteriology Unit, National Institute of Health and Welfare, Helsinki</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Leirisalo Repo, M" sort="Leirisalo Repo, M" uniqKey="Leirisalo Repo M" first="M." last="Leirisalo-Repo">M. Leirisalo-Repo</name>
<affiliation>
<mods:affiliation>Department of Medicine, Division of Rheumat, Helsinki University Central Hospital</mods:affiliation>
<wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BCA9777D929C1E70584B38C4D9896252B982D14B</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1136/annrheumdis-2013-eular.968</idno>
<idno type="url">https://api.istex.fr/document/BCA9777D929C1E70584B38C4D9896252B982D14B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000735</idno>
<idno type="wicri:Area/Istex/Curation">000735</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">THU0440 Yersinia Enterocolitica Biotype 1A Infection can Trigger Reactive Arthritis</title>
<author>
<name sortKey="Tuompo, R" sort="Tuompo, R" uniqKey="Tuompo R" first="R." last="Tuompo">R. Tuompo</name>
<affiliation>
<mods:affiliation>Department of Medicine, Division of Rheumat, Helsinki University Central Hospital</mods:affiliation>
<wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Hannu, T" sort="Hannu, T" uniqKey="Hannu T" first="T." last="Hannu">T. Hannu</name>
<affiliation wicri:level="4">
<mods:affiliation>Hjelt Institute, Department of Public Health, University of Helsinki</mods:affiliation>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Siitonen, A" sort="Siitonen, A" uniqKey="Siitonen A" first="A." last="Siitonen">A. Siitonen</name>
<affiliation wicri:level="1">
<mods:affiliation>Bacteriology Unit, National Institute of Health and Welfare, Helsinki, Finland</mods:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Bacteriology Unit, National Institute of Health and Welfare, Helsinki</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Leirisalo Repo, M" sort="Leirisalo Repo, M" uniqKey="Leirisalo Repo M" first="M." last="Leirisalo-Repo">M. Leirisalo-Repo</name>
<affiliation>
<mods:affiliation>Department of Medicine, Division of Rheumat, Helsinki University Central Hospital</mods:affiliation>
<wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2013-06">2013-06</date>
<biblScope unit="volume">72</biblScope>
<biblScope unit="issue">Suppl 3</biblScope>
<biblScope unit="page" from="A313">A313</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
<idno type="istex">BCA9777D929C1E70584B38C4D9896252B982D14B</idno>
<idno type="DOI">10.1136/annrheumdis-2013-eular.968</idno>
<idno type="href">annrheumdis-72-A313-2.pdf</idno>
<idno type="ArticleID">annrheumdis-2013-eular.968</idno>
<idno type="local">annrheumdis;72/Suppl_3/A313-b</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Background Yersinia enterocolitica (YE) is a well-known trigger of reactive arthritis (ReA) [1]. Studies of YE-related ReA have concentrated on the traditionally pathogenic serotypes O:3 and O:9 (biotypes 4 and 2, respectively) [2, 3]. Biotype 1A is generally considered non-pathogenic [4]. However, biotype 1A has been isolated from stools of diarrheic patients, and the potential pathogenicity of biotype 1A has been discussed in the literature [5, 6]. Objectives To study the capability of YE biotype 1A to induce ReA and other reactive musculoskeletal (MS) symptoms. Methods 406 questionnaires were sent to cases with positive stool culture of YE. Analysis of self-reported MS symptoms was supplemented with a clinical examination of subjects with recent MS symptoms. Results Of the 295 subjects, who returned the questionnaire, 120 reported MS symptoms, of which 114 were included to the final analysis. Among these 114 patients, 77 (68%) had YE biotype 1A, 16 (14%) had YE biotype 4, and one (0.9%) had biotype 2 infection; the remaining 20 (17%) patients had different YE-like strains or had a non-biotypable strain in the stool specimens. Of the subjects, 18% (21/114) fulfilled the criteria for ReA, and a further 12% (14/114) had other reactive MS symptoms (tendinitis or enthesitis). The incidence of ReA was 6% in cases with YE biotype 1 A and 5.4% in cases with biotypes 4 or 2. Conclusions YE biotype 1A can be a causative agent for ReA. Therefore, it should be included among pathogens searched at the diagnostic work up of the aetiology of ReA. References Leirisalo-Repo M. Reactive arthritis. Scand J Rheumatol 2005;34:251-9. Leirisalo M, Skylv G, Kousa M, et al. Followup study on patients with Reiter’s disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982;25:249-9. Schiellerup P, Krogfelt KA, Locht H. A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27.J Rheumatol. 2008;35:480-7. Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997;10:257-76. Tennant SM, Grant TH, Robins-Browne RM. Pathogenicity of Yersinia enterocolitica biotype 1A. FEMS Immunol Med Microbiol 2003;38:127-37. Bhagat N, Virdi JS. The enigma of Yersinia enterocolitica biovar 1A. Crit Rev Microbiol 2010;37:1-15. Disclosure of Interest None Declared</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000735 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000735 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/France
   |area=    LeHavreV1
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:BCA9777D929C1E70584B38C4D9896252B982D14B
   |texte=   THU0440 Yersinia Enterocolitica Biotype 1A Infection can Trigger Reactive Arthritis
}}

Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 14:37:02 2016. Site generation: Tue Mar 5 08:25:07 2024